African Americans are twice as likely to be diagnosed with the rare blood cancer called multiple myeloma than white Americans and other ethnicities. Why is this and what can we do to ensure that this population obtains their very best care? Learn more about the genetics, younger diagnosis and other unique features for these patients and what we could do to increase life expectancy. Dr. Ashraf Badros of the University of Maryland joins us for this important and life-saving show. Thanks to our episode sponsor, Celgene Corporation.